Abstract
Interstitial lung diseases (ILD) are an heterogeneous group of inflammatory diseases characterized by an anatomical distortion of peripheral airways and interstitium, determined by a first stage of alveolitis and a following stage of fibrosis. Natural history of several ILD is characterized by slow and progressive destruction of alveolar-capillary functional units, often with respiratory failure and death. For their smoldering evolution and not specificity of symptoms (exertional dyspnea and cough) ILD may remain not diagnosed and not treated for a long time.
MeSH terms
-
Adrenal Cortex Hormones / administration & dosage
-
Adrenal Cortex Hormones / therapeutic use
-
Adult
-
Anti-Glomerular Basement Membrane Disease / therapy
-
Biopsy
-
Bronchoscopy
-
Cryptogenic Organizing Pneumonia / pathology
-
Humans
-
Immunosuppressive Agents / administration & dosage
-
Immunosuppressive Agents / therapeutic use
-
Lung / diagnostic imaging
-
Lung / pathology
-
Lung Diseases, Interstitial* / classification
-
Lung Diseases, Interstitial* / diagnosis
-
Lung Diseases, Interstitial* / diagnostic imaging
-
Lung Diseases, Interstitial* / etiology
-
Lung Diseases, Interstitial* / pathology
-
Lung Diseases, Interstitial* / therapy
-
Lung Transplantation
-
Middle Aged
-
Plasmapheresis
-
Radiography, Thoracic
-
Radionuclide Imaging
-
Respiratory Function Tests
-
Risk Factors
-
Sarcoidosis, Pulmonary / therapy
-
Tomography, X-Ray Computed
Substances
-
Adrenal Cortex Hormones
-
Immunosuppressive Agents